Skip to main content
Log in

Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas

  • Original paper
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Locally produced pro-inflammatory cytokines are considered to play an important role in the initiation and/or maintenance of inflammatory diseases. In cholesteatomatous lesions there are increased levels of some cytokines and inflammatory mediators like interleukin 1, tumor necrosis factor and colony-stimulating factor, etc. Interleukin 6 (IL-6) can be produced by different cells present in cholesteatoma (e.g. keratinocytes, lymphocytes, fibroblasts and macrophages). Until now, no data have been available on the role of IL-6 in cholesteatoma. In this study we used immunohistochemistry to investigate the presence and distribution of IL-6 in tissue samples from cholesteatoma patients. Levels of the cytokine were quantified in tissue extracts using an enzyme-linked immunosorbent assay. Finally, the presence of biologically active IL-6 was analyzed in the murine cell line 7TD1. Human skin samples obtained from the external ear canal were used as controls. Using the anti-IL-6 antibody in an alkaline phosphatase anti alkaline phosphatase technique, a moderate diffuse staining of the whole epidermis was observed in sections of normal skin. In cryostat sections of cholesteatoma samples, a stronger staining of the whole epithelium was observed. Many of the cells infiltrating the cholesteatoma stroma also showed positive immunostainings. The concentration of IL-6 in relation to the total protein concentration in cholesteatoma (119.33 ± 30) were higher than in human skin (9.16 ± 13). While IL-6 activity was not detected in skin samples, two of the ten cholesteatoma samples studied showed a stimulatory effect when incubated with the cell line 7TD1. The overexpression of IL-6 in middle ear cholesteatoma suggests a participation of this cytokine in some of the clinical features seen: epithelial hyperproliferation and bone resorption. The absence of biological activity in the majority of the cholesteatoma samples points to the presence of natural inhibitors for IL-6.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416

    Google Scholar 

  2. Alm JM, Huang CC, Abramson M (1990) Interleukin-1 causing bone destruction in middle ear cholesteatoma. Otolaryngol Head Neck Surg 103:527–36

    Google Scholar 

  3. Black K, Garret IR, Mundy GR (1991) Chinese hamster ovarian cells transfected with the murine interleukin 6 gene cause hypercalcemia as well as cachexia, leukocyrosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 128:2657–2659

    Google Scholar 

  4. Boxman I, Löwick C, Aarden L, Ponce M (1993) Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol 101:316–324

    Google Scholar 

  5. Bujía J, Holly A, Kim C, Schilling V, Kastenbauer E (1993) Neue Aspekte zur Pathogenese des Cholesteatoms: die m6gliche Rolle einer durch Immunzellen induzierten Keratinozyten-Hyperproliferation. Laryngorhinootologie 72:247–283

    Google Scholar 

  6. Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P (1993) Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 103:326–329

    Google Scholar 

  7. Bujía J, Schilling V, Holly A, Stammberger M, Kastenbauer E (1993) Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 113: 364–368

    Google Scholar 

  8. Content J, De Witt L, Poupart P, Opdenakker G, Van Damme J, Billiau A (1985) Induction of a 2-kDa-protein mRNA in human cells treated with an interleukin 1-related, leukocyte-derived factor. Eur J Biochem 152:253–258

    Google Scholar 

  9. Frei K, Leist TP, Meager A, Gallo P, Leppert D, Zinkernagel RM, Fontana A (1988) Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. J Exp Med 168:449–453

    Google Scholar 

  10. Helle M, Boije L, Aarden LA (1988) Functional discrimination between interleukin 6 and interleukin l. Eur J Immunol 18: 1535–1540

    Google Scholar 

  11. Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of inteleukin-6. Immunol Today 11:443–449

    Google Scholar 

  12. Huang T, Yan SD, Huang CC (1989) Colony-stimulating factor in middle ear cholesteatoma. Am J Otolaryngol 10:393–398

    Google Scholar 

  13. Hültner L, Moeller J (1990) Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline. Exp Hematol 18:873–887

    Google Scholar 

  14. Ishimi Y, Miyaura C, Kin CH, Akatsu T, Abe T, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297–3303

    Google Scholar 

  15. Kohase M, Henriksen D, May LT, Vilcek J, Sehgal PB (1986) Induction of beta 2 interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–662

    Google Scholar 

  16. Matsuda T, Hirano T, Kishimoto T (1988) Establishment of an interleukin 6 (IL6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur J Immunol 18:951–995.

    Google Scholar 

  17. May LT, Helfgott DC, Sehgal PB (1986) Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved. Proc Natl Acad Sci USA 83:8957–8961

    Google Scholar 

  18. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–60

    Google Scholar 

  19. Mundy GR (1993) Role of cytokines in bone resorption. J Cell Biochem 53:296–300

    Google Scholar 

  20. Palva T (1990) The pathogenesis and treatment of cholesteatoma. Acta Otolaryngol (Stockh) 109:323–330

    Google Scholar 

  21. Prens EP, Benne K, Van Damme J, Bakkus M, Brakel K, Benner R, Van Joost T (1990) Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol 95:121S-124S

    Google Scholar 

  22. Roodman GD, Kurihara N, Ohsaki Y, Kukita T, Hosking D, Demulder A, Singer FR (1991) Interleukin 6: a potential autocrine paracrine factor in Paget's disease of bone. J Clin Invest 89:46–52

    Google Scholar 

  23. Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E (1992) Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 13:350–355

    Google Scholar 

  24. Schulz P, Bujia J, Holly A, Schilling V, Kastenbauer E (1993) Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol 14:82–87

    Google Scholar 

  25. Seghal PB (1990) Interleukin-6: molecular pathophysiology. J Invest Dermatol 94:2S-6S

    Google Scholar 

  26. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Van Snick J (1987) Identification of the human 26-kD protein interferon beta 2 as a B cell hybridoma (plasmacytoma) growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165:914–920

    Google Scholar 

  27. Van Snick K (1990) Interleukin-6: an overview. Annu Rev Immunol 8:253–278

    Google Scholar 

  28. Van Snick K, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679–9683

    Google Scholar 

  29. Vink A; Coulie PG, Wauters P, Nordan RP, Van Snick K (1988) B cell growth and differentiation activity of interleukinHP1 and related marine planacytoma growth factors. Synergy with interleukin 1. Eur J Immunol 18:607–610

    Google Scholar 

  30. Wong GG, Clark SC (1988) Multiple actions of interleukin 6 within cytokine network. Immunol Today 9:137–141

    Google Scholar 

  31. Yan SD, Huang CC (1991) Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Ann Otol Rhinol Laryngol 100:157–161

    Google Scholar 

  32. Yan SD, Huang CC (1991) Lymphotoxin in human middle car cholesteatoma. Laryngoscope 101:411–415

    Google Scholar 

  33. Yellon RF, Leonard G, Marucha P, Sidman J, Carpenter R, Burleson J, Carlson J, Kreutzer D (1992) Demonstration of interleukin 6 in middle ear effusions. Arch Otolarygnol Head Neck Surg 118:745–748

    Google Scholar 

  34. Yoshizaki K, Nishimoto N, Matsumoto K, Tagoh H, Taga T, Deguchi Y, Kuritani T, Hirano T, Hashimoto K, Okada N, Kishimoto T (1990) Interleukin 6 and expression of its receptor on epidermal keratinocytes. Cytokine 2:381–387

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bujía, J., Kim, C., Ostos, P. et al. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 253, 152–157 (1996). https://doi.org/10.1007/BF00615113

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00615113

Key words

Navigation